XL-184+Abiraterone in Post-Chemo CRPC

This study is currently recruiting participants.
Verified January 2014 by Dana-Farber Cancer Institute
Sponsor:
Information provided by (Responsible Party):
Christopher Sweeney, MBBS, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01574937
First received: April 8, 2012
Last updated: January 14, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)